Jad Othman

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 30

Top Venues

Blood

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Internal medicine journal

Blood advances

This page only lists publications with an associated author ORCID identifier.

Publications

Jad Othman, Nicola Potter, Adam Ivey, Jelena Jovanovic, Manohursingh Runglall, Sylvie D Freeman, Amanda Frances Gilkes, Ian Thomas, Sean J Johnson, Joanna Canham, James Durrell Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan K Burnett, Charlotte S Wilhelm-Benartzi, Richard Dilon, Nigel H Russell
Post induction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood (2024)
Jad Othman, Nicola Potter, Adam Ivey, Yanis Tazi, Elli Papaemmanuil, Jelena Jovanovic, Sylvie D Freeman, Amanda Frances Gilkes, Rosemary E Gale, Tanya Rapoz-D'Silva, Manohursingh Runglall, Michelle Kleeman, Pawan Dhami, Ian Thomas, Sean J Johnson, Joanna Canham, James Durrell Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Kenneth Burnett, Charlotte S Wilhelm-Benartzi, Brian James Patrick Huntly, Nigel H Russell, Richard James Dillon
Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML. Blood (2024)
Jad Othman, Nicola Potter, Adam Ivey, Jelena Jovanovic, Manohursingh Runglall, Sylvie D Freeman, Amanda Gilkes, Ian Thomas, Sean J Johnson, Joanna Canham, Jamie Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Burnett, Charlotte Wilhelm-Benartzi, Richard Dilon, Nigel H Russell
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood 143 (19) (2024)
Jad Othman, Angela Hwang, Maximillian Hugo Brodermann, Islam Abdallah, Kayleigh McCloskey, Paolo Gallipoli, Georgina Clarke, Raymond Dang, Jenniner Vidler, Pramila Krishnamurthy, Faisal Basheer, Anne-Louise Latif, Renuka Palanicawandar, Thomas Taylor, Asra Khan, Victoria Campbell, Francesca Hogan, Alexandros Kanellopoulos, Kathryn Fleming, Angela Collins, Christopher Dalley, Justin Loke, Scott Marshall, David Taussig, Sreetharan Munisamy, Eleana Loizou, Heba Yassin, Mike Dennis, Rui Zhao, Edward Belsham, Duncan Murray, Nicole Fowler, Jenny O'Nions, Anjum Bashir Khan, Rob S Sellar, Richard James Dillon
Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy. Blood advances (2024)
George Mason, Rhian Aghajani, Brieanna Dance, Jad Othman, Linda Goodwin, William Stevenson, Naomi Mackinlay
Chronic myeloproliferative neoplasm in adulthood in CBL syndrome harboring a splice-site CBL variant alongside a novel constitutional CSF3R variant. EJHaem 5 (2) (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jad Othman, Nicola Potter, Adam Ivey, Jelena Jovanovic, Manohursingh Runglall, Sylvie D Freeman, Amanda Gilkes, Ian Thomas, Sean J Johnson, Joanna Canham, Jamie Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Burnett, Charlotte Wilhelm-Benartzi, Richard Dilon, Nigel H Russell
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood 143 (19) (2024)
Jad Othman, Nicola Potter, Adam Ivey, Jelena Jovanovic, Manohursingh Runglall, Sylvie D Freeman, Amanda Gilkes, Ian Thomas, Sean J Johnson, Joanna Canham, Jamie Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Burnett, Charlotte Wilhelm-Benartzi, Richard Dilon, Nigel H Russell
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood 143 (19) (2024)
Jad Othman, Nicola Potter, Adam Ivey, Yanis Tazi, Elli Papaemmanuil, Jelena Jovanovic, Sylvie D Freeman, Amanda Gilkes, Rosemary E Gale, Tanya Rapoz-D'Silva, Manohursingh Runglall, Michelle Kleeman, Pawan Dhami, Ian Thomas, Sean J Johnson, Joanna Canham, Jamie Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Burnett, Charlotte Wilhelm-Benartzi, Brian James Patrick Huntly, Nigel H Russell, Richard Dillon
Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML. Blood 144 (7) (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
George Mason, Rhian Aghajani, Brieanna Dance, Jad Othman, Linda Goodwin, William Stevenson, Naomi Mackinlay
Chronic myeloproliferative neoplasm in adulthood in CBL syndrome harboring a splice-site CBL variant alongside a novel constitutional CSF3R variant. EJHaem 5 (2) (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
George Mason, Rhian Aghajani, Brieanna Dance, Jad Othman, Linda Goodwin, William Stevenson, Naomi Mackinlay
Chronic myeloproliferative neoplasm in adulthood in CBL syndrome harboring a splice-site CBL variant alongside a novel constitutional CSF3R variant. EJHaem 5 (2) (2024)
Jad Othman, Nicola Potter, Adam Ivey, Jelena Jovanovic, Manohursingh Runglall, Sylvie D Freeman, Amanda Frances Gilkes, Ian Thomas, Sean J Johnson, Joanna Canham, James Durrell Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan K Burnett, Charlotte S Wilhelm-Benartzi, Richard Dilon, Nigel H Russell
Post induction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Carlos Jimenez Chillon, Jad Othman, David Taussig, Carlos Jiménez-Vicente, Alexandra Martínez-Roca, Ing Soo Tiong, Manish Jain, James Aries, Seda Cakmak, Stephen Knapper, Daniel Tuyet Kristensen, Vidhya Murthy, Zacharoula Galani, Charlotte Kallmeyer, Loretta Ngu, David Veale, Simon Bolam, Nina Orfali, Anne Parker, Cara Manson, Jane Parker, Thomas Erblich, Deborah Susan Richardson, Katya Mokretar, Nicola Potter, Ulrik Malthe Overgaard, Anne Stidsholt Roug, Andrew H Wei, Jordi Esteve, Martin Jädersten, Nigel H Russell, Richard Dilon
Venetoclax-based low intensity therapy in molecular failure of NPM1 mutated AML. Blood advances (2023)
Jad Othman, Charlotte S Wilhelm-Benartzi, Richard Dilon, Stephen Knapper, Sylvie D Freeman, Leona M Batten, Joanna Canham, Emily L Hinson, Julie Wych, Sophie Betteridge, William Villiers, Michelle Kleeman, Amanda Frances Gilkes, Nicola Potter, Ulrik Overgaard, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Jane Hemmaway, Claire Arnold, Mike Dennis, Nigel H Russell
A Randomised Comparison of CPX-351 and FLAG-Ida in Adverse Karyotype AML and High-Risk MDS: The UK NCRI AML19 Trial. Blood advances (2023)
Richard Blennerhassett, Jad Othman, Amber Biscoe, David Kliman, Georgia Mills, Emily Blyth, Kenneth Micklethwaite, John Kwan, Ian Bilmon, Abir Bhattacharyya, Shyam Panicker, Keith Fay, Sam Milliken, David Ma, Nada Hamad, William Stevenson, Chris Arthur, John Moore, Matthew Greenwood, David Gottlieb, Ian Kerridge
Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis. Internal medicine journal (2023)
Richard Blennerhassett, Jad Othman, Amber Biscoe, David Kliman, Georgia Mills, Emily Blyth, Kenneth Micklethwaite, John Kwan, Ian Bilmon, Abir Bhattacharyya, Shyam Panicker, Keith Fay, Sam Milliken, David Ma, Nada Hamad, William Stevenson, Chris Arthur, John Moore, Matthew Greenwood, David Gottlieb, Ian Kerridge
Long term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic hematopoietic stem cell transplant: A comparative cohort analysis. Internal medicine journal (2023)
Jad Othman, Nicola Potter, Katya Mokretar, David Taussig, Anjum Khan, Pramila Krishnamurthy, Anne-Louise Latif, Paul Cahalin, James Aries, Mariam Amer, Edward Belsham, Eibhlin Conneally, Charles F Craddock, Dominic Culligan, Mike Dennis, Caroline Duncan, Sylvie D Freeman, Caroline Furness, Amanda Gilkes, Paraskevi Gkreka, Katherine Hodgson, Wendy Ingram, Manish Jain, Andrew King, Stephen Knapper, Panagiotis Kottaridis, Mary Frances Frances McMullin, Unmesh Mohite, Loretta Ngu, Jenny O'Nions, Katharine Patrick, Tom Rider, Wing Roberts, Marianne Tang Severinsen, Neill Storrar, Tom Taylor, Nigel H Russell, Richard Dilon
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML. Leukemia (2023)
Jad Othman, Ing Soo Tiong, Jenny O'Nions, Mike Dennis, Katya Mokretar, Adam Ivey, Michael James Austin, Annie-Louise Latif, Mariam Amer, Wei Yee Chan, Charles R Crawley, Francesca Crolla, Joe Wilson Cross, Raymond Dang, Johnathon Elliot, Chun Yew Fong, Sofia Galli, Paolo Gallipoli, Francesca Hogan, Pallavi Kalkur, Anjum Bashir Khan, Pramila Krishnamurthy, John Laurie, Sun Loo, Scott Marshall, Priyanka Mehta, Vidhya Murthy, Sateesh K Nagumantry, Srinivas Pillai, Nicola Potter, Rob S Sellar, Thomas Taylor, Rui Zhao, Nigel H Russell, Andrew H Wei, Richard Dilon
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based non-intensive therapy. Blood (2023)
Jad Othman, Manja Meggendorfer, Enrico Tiacci, Christian Thiede, Richard F Schlenk, Richard Dilon, Sebastian Stasik, Alessandra Venanzi, Sarah Bertoli, Eric Delabesse, Pierre-Yves Dumas, Arnaud Pigneux, Audrey Bidet, Amanda Frances Gilkes, Ian Thomas, Maria Teresa Teresa Voso, Alessandro Rambaldi, Lorenzo Brunetti, Vincenzo Maria Perriello, Vibeke Andresen, Bjorn T Gjertsen, Maria Paola Martelli, Christian Recher, Hubert Serve, Carsten Muller-Tidow, Claudia D Baldus, Torsten Haferlach, Nigel H Russell, Brunangelo Falini
Overlapping features of therapy-related and de novoNPM1-mutated AML. Blood (2022)
Jad Othman, Manja Meggendorfer, Enrico Tiacci, Christian Thiede, Richard F Schlenk, Richard Dilon, Sebastian Stasik, Alessandra Venanzi, Sarah Bertoli, Eric Delabesse, Pierre-Yves Dumas, Arnaud Pigneux, Audrey Bidet, Amanda Frances Gilkes, Ian Thomas, Maria Teresa Teresa Voso, Alessandro Rambaldi, Lorenzo Brunetti, Vincenzo Maria Perriello, Vibeke Andresen, Bjorn T Gjertsen, Maria Paola Martelli, Christian Recher, Christoph Röllig, Martin Bornhäuser, Hubert Serve, Carsten Muller-Tidow, Claudia D Baldus, Torsten Haferlach, Nigel H Russell, Brunangelo Falini
Overlapping features of therapy-related and de novoNPM1-mutated AML. Blood (2022)
Jad Othman, Manja Meggendorfer, Enrico Tiacci, Christian Thiede, Richard F Schlenk, Richard Dilon, Sebastian Stasik, Alessandra Venanzi, Sarah Bertoli, Eric Delabesse, Pierre-Yves Dumas, Arnaud Pigneux, Audrey Bidet, Amanda Frances Gilkes, Ian Thomas, Maria Teresa Teresa Voso, Alessandro Rambaldi, Lorenzo Brunetti, Vincenzo Maria Perriello, Vibeke Andresen, Bjorn T Gjertsen, Maria Paola Martelli, Christian Recher, Christoph Röllig, Martin Bornhäuser, Hubert Serve, Carsten Muller-Tidow, Claudia D Baldus, Torsten Haferlach, Nigel H Russell, Brunangelo Falini
Overlapping features of therapy-related and de novoNPM1-mutated AML. Blood (2022)
Jad Othman, Donna Aarons, Ashish Bajel, Jason Butler, Richard Doocey, Tracey O'Brien, Duncan Purtill, Lisa Smith, Leonie Wilcox, Nada Hamad
Allogeneic haemopoietic cell transplant services in Australia and New Zealand in the first year of the COVID-19 pandemic: a report from Australia and New Zealand transplant and cellular therapies. Internal medicine journal (2022)
Jessica Bui, Rochelle Gellatly, Jad Othman, Julian Lindsay
Subtherapeutic concentrations of posaconazole tablet: determining risk factors and effectiveness of a standardized dose adjustment in hematology inpatients. Leukemia & lymphoma (2022)
Sun Loo, Richard Dillon, Adam Ivey, Natasha S Anstee, Jad Othman, Ing Soo Tiong, Nicola Potter, Jelena Jovanovic, Manohursingh Runglall, Chyn Chua Chong, Ashish Bajel, David Ritchie, Kelli Gray, Zhi Han Yeoh, Michelle McBean, Amanda Gilkes, Ian Thomas, Sean J Johnson, Nigel H Russell, Andrew H Wei
Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome. Blood 140 (22) (2022)
Jad Othman, Tasman Armytage, Kelly Wong, Christopher Arthur, Keith Fay, William Stevenson, Naomi MacKinlay, Christopher Ward, Victoria Pechey, Luke Coyle, Ian Kerridge, Matthew Greenwood
Intensive chemotherapy and up-front stem cell transplant for double hit lymphoma. Bone marrow transplantation 55 (7) (2020)
Jad Othman, Fiona Bonar, Wendy Brown, Richard Boyle, Teh-Liane Khoo
Multiply relapsed mixed histiocytosis in an adult responding to clofarabine after failure of cladribine. Leukemia & lymphoma 61 (2) (2019)
Jad Othman, Christina M Brown
Talaromyces marneffei and dysplastic neutrophils on blood smear in newly diagnosed HIV. Blood 131 (2) (2019)

Jad Othman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jad Othman